Product Liability Law for U.S. Businesses

Product liability law governs the legal responsibility of manufacturers, distributors, wholesalers, and retailers when a defective product causes injury or property damage. In the United States, this body of law operates primarily through state tort systems, with federal regulatory frameworks layered on top through agencies such as the Consumer Product Safety Commission (CPSC) and the Food and Drug Administration (FDA). Understanding how liability attaches — and which party in the supply chain bears it — is essential for any business that designs, makes, or sells physical goods. This page covers the foundational doctrines, the mechanics of how claims are established, common commercial scenarios, and the key legal boundaries that determine exposure.

Definition and Scope

Product liability refers to the set of legal rules under which a business entity may be held financially responsible for harm caused by a product it placed into the stream of commerce. Unlike ordinary negligence claims, product liability in most U.S. jurisdictions does not require the injured party to prove that the defendant acted carelessly — strict liability doctrine, adopted by the majority of states following the framework articulated in Restatement (Second) of Torts § 402A (1965), allows recovery based solely on the existence of a defect and causation of harm.

The scope of covered parties is broader than many businesses anticipate. Courts have consistently held that strict liability can attach to any commercial seller in the distribution chain, including component-part manufacturers, assemblers, distributors, and retail sellers — not only the original manufacturer. The Uniform Commercial Code (UCC), adopted in all 50 states in some form, adds an additional layer through implied warranties of merchantability and fitness, which run independently of tort claims.

Federal preemption is a persistent jurisdictional question. The CPSC administers the Consumer Product Safety Act (15 U.S.C. §§ 2051–2089), which sets mandatory safety standards for thousands of product categories and can, in certain circumstances, preempt state tort claims — though courts apply this doctrine narrowly. The FDA similarly regulates medical devices and food products, and its preemption arguments under the Medical Device Amendments of 1976 (21 U.S.C. § 360k) have produced a split body of federal case law.

How It Works

A product liability claim in the U.S. proceeds through three foundational elements, regardless of the specific theory of recovery:

1. The product was defective. The defect must fall into one of three recognized categories: manufacturing defect, design defect, or failure to warn (marketing defect).
2. The defect existed when the product left the defendant's control. A post-sale modification by the buyer or a third party can sever the causal chain.
3. The defect caused the plaintiff's injury or property damage. Both cause-in-fact and proximate causation must be established.

Three Theories of Liability — Compared

Design defect claims involve the most significant litigation complexity. Two competing legal tests exist: the consumer expectations test (asks whether the product is more dangerous than an ordinary consumer would expect) and the risk-utility test (weighs the probability and severity of harm against the cost of a safer design). California applies both under its judicial framework; many other states have moved to the risk-utility analysis as the primary standard.

Defendants may raise several affirmative defenses. Contributory or comparative fault, assumption of risk, and product misuse are the most frequently litigated. Under pure comparative fault systems (used by 13 states), a plaintiff's damages are reduced in proportion to their own fault but not eliminated. Under modified comparative fault systems (the majority approach), plaintiffs are barred from recovery if their fault exceeds 50% or 51% depending on the state.

The business litigation process for product liability cases typically involves expert testimony on both product design and medical causation, making these among the most discovery-intensive commercial disputes. Plaintiffs often name every entity in the supply chain initially, with cross-claims and indemnification agreements between co-defendants resolving the ultimate allocation of liability.

Common Scenarios

Retail and distribution businesses face exposure even when they played no role in product design or manufacturing. A retailer that sells a defective ladder, power tool, or food product can be named as a strict liability defendant under the laws of states that have not adopted the "seller's exception" (roughly 20 states have enacted statutes that shield non-manufacturing sellers under certain conditions, often requiring the plaintiff to first seek recovery from the manufacturer).

Component-part manufacturers are a distinct category. If a defective component — a battery cell, a valve, a microprocessor — causes injury when integrated into a finished product, both the component maker and the final assembler may face liability under the "component parts doctrine," though courts examine whether the component itself was defective or whether the defect arose from integration.

Software-integrated products present an emerging area. The e-commerce and digital business law landscape increasingly intersects with product liability as connected devices, autonomous vehicle systems, and AI-governed equipment reach consumers. Courts and legislators have not yet uniformly resolved whether embedded software is treated as a "product" subject to strict liability or a "service" governed by negligence standards.

Food and pharmaceutical products are subject to FDA oversight under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.) and remain among the highest-volume product liability categories in federal multidistrict litigation.

Decision Boundaries

The boundaries that determine whether product liability applies — and which doctrine controls — turn on several classification questions.

Strict liability vs. negligence: Most U.S. jurisdictions apply strict liability to manufacturing defects and, increasingly, to design and warning defects as well. A negligence framework requires proof of unreasonable conduct, which is a higher plaintiff burden but allows defendants to demonstrate that industry standards were followed. Following Restatement (Third) of Torts: Products Liability (1998), a growing minority of states have moved toward negligence-like risk-utility analysis for design and warning claims while retaining strict liability for manufacturing defects.

Product vs. service: Pure service transactions are not subject to product liability doctrine. Courts apply multi-factor tests to hybrid transactions — for example, a restaurant meal is typically classified as a product sale in most states, while a medical procedure involving an implanted device may be classified as a service in jurisdictions following the "gravamen of the transaction" test.

Preemption boundaries: Federal preemption of state product liability claims is fact-specific. The U.S. Supreme Court addressed device preemption in Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), holding that Class III medical devices with premarket approval preempt state design and warning claims. Drug labeling preemption was addressed in Wyeth v. Levine, 555 U.S. 555 (2009), which held that FDA approval does not generally preempt state failure-to-warn claims for prescription drugs. These two decisions mark the operative boundary for pharmaceutical and device manufacturers.

Indemnification and supply chain allocation: Businesses in the distribution chain can shift liability contractually through indemnification agreements and insurance requirements in commercial contracts. The enforceability of these provisions is governed by state contract law; contract law for businesses and business insurance and liability law govern the structural mechanisms for risk transfer upstream to the manufacturer or downstream insurer.

The intersection of product liability with business tort law arises when claims include fraud, concealment of known defects, or intentional misrepresentation — conduct that can support punitive damages beyond compensatory recovery and, in some states, trigger enhanced penalty exposure under consumer protection statutes.

References

• Consumer Product Safety Act, 15 U.S.C. §§ 2051–2089 — U.S. Consumer Product Safety Commission
• Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq. — U.S. Food and Drug Administration
• Medical Device Amendments of 1976, 21 U.S.C. § 360k — FDA
• Restatement (Second) of Torts § 402A — American Law Institute
• Restatement (Third) of Torts: Products Liability (1998) — American Law Institute
• Riegel v. Medtronic, Inc., 552 U.S. 312 (2008) — Supreme Court of the United States
• Wyeth v. Levine, 555 U.S. 555 (2009) — Supreme Court of the United States
• Uniform Commercial Code — Uniform Law Commission